Structure Therapeutics Inc. American Depositary Shares (GPCR)

NASDAQ HEALTHCARE
$43.56 -3.90% RSI 28 Oversold Add Alert

Moving Averages

SMA 200
$42.60
Price near

Company Profile

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$3.86B
P/E Ratio
None
EPS
$-2.4
Beta
-1.252
Dividend Yield
0.00%
52-Week High
$94.9
52-Week Low
$15.8

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 45.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0

Data last updated: April 11, 2026 at 9:04 PM EDT

Track GPCR for free

Get e-mail RSI alerts when Structure Therapeutics Inc. American Depositary Shares enters oversold or overbought territory. Free forever.

Add Alert